Ann: Invitation to attend presentation, page-2

Taken from ASX announcement 26th Nov 19'

Next Steps
The development focus is on manufacturing a commercially viable graphene-based biosensor
technology and the registration of a full patent application protecting the underlying materials
technology IP. This involves optimising ink formulations and their processing methods linked to
the provisional patent claims, and identifying transduction methods, bioreceptors, analytes,
coupling and assay reagents for the proper function of the biosensor technology.
Archer intends to commercialise the biosensing technology by seeking to establish commercial
partnerships, including licencing agreements, with highly resourced organisations including
biotechnology companies, that could allow for product scale, IP transfer, and distribution
channels.

Obviously these presentations will co-inside with the lodgement of the full patient..!!!
Good news pending...